Trials / Completed
CompletedNCT00462540
A Crossover Study in the Treatment of Patients With COPD
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Dey · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy of Formoterol Fumarate Inhalation Solution (FFIS) 20 mcg BID to Combivent® Inhalation Aerosol \[2 inhalations from metered dose inhaler (MDI)of 18 mcg ipratropium bromide and 103 mcg albuterol sulfate QID\], and to Compare the preference/compliance of BID nebulization to QID use of MDI
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Formoterol Fumurate inhalation solution 20 mcg | |
| DRUG | Ipratropium bromide 18 mcg and albuterol sulfate 103 mcg |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2007-09-01
- Completion
- 2007-10-01
- First posted
- 2007-04-19
- Last updated
- 2009-03-04
Locations
15 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00462540. Inclusion in this directory is not an endorsement.